目次

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary
3.1 Market Summary

Chapter 4 Global Nanomedicine Market Variables, Trends, & Scope
4.1 Nanomedicine Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rising Level Of Government Participation In R&D Funding
4.4.2 Introduction Of Technological Advancements In Diagnostic Procedures
4.4.3 Rising Usage Of Nanomedicine In Drug Delivery Technology
4.5 Market Restraint Analysis
4.5.1 Side Effects Associated With Intake Of Nanoparticles And Lower Adoption Rate By Patients
4.5.2 Hesitant Uptake By Medical And Pharmaceutical Industry
4.6 Porter’s Five Forces Analysis
4.7 SWOT Analysis
4.8 COVID-19 Impact Analysis

Chapter 5 Nanomedicine Market- Segment Analysis, by Application, 2018 - 2030 (USD Million)
5.1 Global Nanomedicine Market: Application Movement Analysis
5.2 Therapeutics
5.2.1 Therapeutics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Active Implants
5.3.1 Active Implants Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 In-Vitro Diagnostics
5.4.1 In-Vitro Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Drug Delivery
5.5.1 Drug Delivery Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 In-Vivo Imaging
5.6.1 In-Vivo Imaging Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Implants
5.7.1 Implants Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Nanomedicine Market - Segment Analysis, by Indication, 2018 - 2030 (USD Million)
6.1 Global Nanomedicine Market: Indication Movement Analysis
6.2 Clinical Oncology
6.2.1 Clinical Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Infectious Diseases
6.3.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Clinical Cardiology
6.4.1 Clinical Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.5 Orthopedics
6.5.1 Orthopedics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Nanomedicine Market - Segment Analysis, By Molecule Type, 2018 - 2030 (USD Million)
7.1 Nanomedicine Market: Molecule Type Movement Analysis
7.2 Nanoparticles
7.2.1 Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2 Metal & Metal Oxide Nanoparticles
7.2.2.1 metal & Metal Oxide NanoparticlesMarket Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.3 Liposomes
7.2.3.1 liposomes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.4 Polymers & Polymer Drug Conjugates
7.2.4.1 Polymers & Polymer Drug Conjugates Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.5 Hydrogel Nanoparticles
7.2.5.1 Hydrogel Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.6 Dendrimers
7.2.6.1 Dendrimers Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.7 Inorganic Nanoparticles
7.2.7.1 Inorganic Nanoparticles Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Nanoshells
7.3.1 Nanoshells Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4. Nano Tubes
7.4.1 Nanotubes Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Nanodevices
7.5.1 Nanodevices Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Nanomedicine Market: - Segment Analysis, By Region, 2018 - 2030 (USD Million)
8.1 nanomedicine Market: Regional Movement Analysis
8.2 north America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4.France
8.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4india
8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Australia Market estimates and forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Market estimates and forecast, 2018 - 2030 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 ABBOTT LABORATORIES
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 COMBIMATRIX CORPORATION
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 CELGENE CORPORATION
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 NANOSPECTRA BIOSCIENCES, INC.
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 GENERAL ELECTRIC
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 JOHNSON & JOHNSON SERVICES, INC.
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 MALLINCKRODT PHARMACEUTICALS
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 MERCK & CO., INC.
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 PFIZER, INC.
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 TEVA PHARMACEUTICAL INDUSTRIES LTD.
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 ARROWHEAD PHARMACEUTICALS, INC.
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives

List of Tables
Table 1 Global Nanomedicine Market, By Region, 2018 - 2030 (USD Million)
Table 2 Global Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 3 Global Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 4 Global Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 5 North America Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 6 North America Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 7 North America Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 8 North America Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 9 U.S. Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 10 U.S. Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 11 U.S. Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 12 Canada Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 13 Canada Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 14 Canada Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 15 Europe Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 16 Europe Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 17 Europe Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 18 Europe Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 19 UK Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 20 UK Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 21 UK Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 22 Germany Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 23 Germany Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 24 Germany Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 25 France Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 26 France Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 27 France Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 28 Italy Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 29 Italy Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 30 Italy Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 31 Spain Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 32 Spain Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 33 Spain Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 36 Asia Pacific Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 38 Japan Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 39 Japan Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 40 Japan Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 41 China Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 42 China Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 43 China Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 44 India Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 45 India Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 46 India Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 47 Australia Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 48 Australia Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 49 Australia Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 50 South Korea Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 51 South Korea Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 52 South Korea Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 53 Latin America Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 54 Latin America Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 55 Latin America Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 56 Latin America Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 57 Brazil Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 58 Brazil Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 59 Brazil Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 60 Mexico Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 61 Mexico Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 62 Mexico Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 63 Argentina Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 64 Argentina Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 65 Argentina Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa Nanomedicine Market, By Country, 2018 - 2030 (USD Million)
Table 67 Middle East & Africa Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 68 Middle East & Africa Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 69 Middle East & Africa Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 70 South Africa Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 71 South Africa Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 72 South Africa Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)
Table 76 UAE Nanomedicine Market, By Indication, 2018 - 2030 (USD Million)
Table 77 UAE Nanomedicine Market, By Application, 2018 - 2030 (USD Million)
Table 78 UAE Nanomedicine Market, By Molecule Type, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Nanomedicine market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration Vs Growth Prospect Mapping
Fig. 15 Nanomedicine market: Application Movement Analysis
Fig. 16 Nanomedicine market: Indication Movement Analysis
Fig. 17 Nanomedicine market: Molecule Type Movement Analysis
Fig. 18 Regional Marketplace: Key Takeaways
Fig. 19 Regional Outlook, 2018 & 2030
Fig. 20 North America Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 21 U.S. Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 22 Canada Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 23 Europe Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 24 UK Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 25 Germany Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 26 France Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 27 Italy Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 28 SpainNanomedicine market, 2018 - 2030 (USD Million)
Fig. 29 Asia Pacific Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 30 Japan Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 31 China Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 32 India Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 33 South Korea Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 34 Australia Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 35 Latin America Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 36 Brazil Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 37 Mexico Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 38 Argentina Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 39 MEA Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 40 South Africa Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 41 Saudi Arabia Nanomedicine market, 2018 - 2030 (USD Million)
Fig. 42 UAE Nanomedicine market, 2018 - 2030 (USD Million)